Gilead Faces Doubts on Wall Street a Year After $12 Billion Deal
Investors Cash Out of Biotech ETF as M&A Boom Never Materializes
Pot Stocks Aside, Canadian Equity Market Limps Into September
Gene-Editing Patent Challenge Rejected by U.S. Appeals Court
‘Goldilocks’ Effect Has JPMorgan Liking Hospitals and Insurers
The Future of Medicine May Land Within Five to 10 Years
The billionaire has donated millions gift to setup neuroscience institutes California Institute of Technology, Fudan University.
Health Stocks Look Increasingly Bright to Trade-Weary Investors
Investors Cash Out of HCA Healthcare as Stock Soars to Record
Glenview, Icahn Face Off Over Cigna/Express Scripts Deal
Rite Aid Guidance Cut a 'Tough Blow' Ahead of Albertsons Vote
Builders to Banks Stand to Reap Long-Term Rewards, Smead Says
Investors Take a Shine to Henry Schein, Doubting Amazon Threat
Community Health Systems Inc. may be on life support, but its largest shareholder isn’t ready to pull the plug.
Hospitals Rally With Investors Pinning Hopes on Private Equity Buyers
It looks like the decade-long bull market in U.S. stocks has more room to run, albeit with less vigor.
Tech ‘Euphoria’ Could Permanently Damage Returns, Smead Says
Insurers Overtake Hospitals Pre-Earnings as Traders Reverse Bets
Build-A-Bear Jumps, Breaks Hearts After Sale Mayhem
Forget Drug Pricing, Pharma’s Bigger Burden Is a Dearth of M&A
Indian market “most interesting” given its democratic society and growing population base, said this market veteran